SCHEMBL14720801

SCHEMBL14720801

CCN1CCC(=Cc2ccc(C#N)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.47
RAB9A P51151 1/20 0.40
KCNJ1 P48048 1/20 0.40
KCNH2 Q12809 1/20 0.40
DRD2 P14416 3/20 0.40
DRD3 P35462 3/20 0.40
CYP2A6 P11509 1/20 0.39
MAOB P27338 2/20 0.39
CHRNA10 Q9GZZ6 1/20 0.38
CHRNA9 Q9UGM1 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
OGA O60502 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720922 0.87 DRD3 (0.53) HRH3RAB9AKCNJ1KCNH2DRD2
SCHEMBL1483704 0.83 RAB9A (0.53) HRH3RAB9AKCNJ1KCNH2DRD2
SCHEMBL2514685 0.81 HRH3 (0.52) HRH3DRD2DRD3ALDH1A1
SCHEMBL14721386 0.80 GPR183 (0.49) HRH3DRD3OGA
SCHEMBL14721028 0.80 HRH3 (0.45) HRH3CYP2A6ALDH1A1KDM4ELMNA
SCHEMBL18741389 0.80 HRH3 (0.47) HRH3DRD2ALDH1A1KDM4EGAA
SCHEMBL14720404 0.75 ALDH1A1 (0.46) MAOBALDH1A1KDM4ELMNAMAPT
SCHEMBL14721932 0.75 GPR183 (0.45) HRH3DRD3OGA
SCHEMBL14722734 0.75 OGA (0.52) HRH3ALDH1A1KDM4ELMNAOGA
SCHEMBL376663 0.73 KDM4E (0.67) DRD2DRD3MAOBCHRNA10CHRNA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed